ELUT
Price
$1.72
Change
-$0.02 (-1.15%)
Updated
May 22, 10:30 AM (EDT)
Capitalization
76.46M
76 days until earnings call
STRRP
Price
$9.17
Change
-$0.43 (-4.48%)
Updated
May 22, 11:43 AM (EDT)
Capitalization
N/A
Interact to see
Advertisement

ELUT vs STRRP

Header iconELUT vs STRRP Comparison
Open Charts ELUT vs STRRPBanner chart's image
Elutia
Price$1.72
Change-$0.02 (-1.15%)
VolumeN/A
Capitalization76.46M
Star Equity Holdings
Price$9.17
Change-$0.43 (-4.48%)
Volume$2K
CapitalizationN/A
ELUT vs STRRP Comparison Chart
Loading...
ELUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELUT vs. STRRP commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELUT is a Hold and STRRP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (ELUT: $1.74 vs. STRRP: $9.60)
Brand notoriety: ELUT and STRRP are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ELUT: 40% vs. STRRP: 34%
Market capitalization -- ELUT: $76.46M vs. STRRP: $0
ELUT [@Medical Specialties] is valued at $76.46M. STRRP’s [@Medical Specialties] market capitalization is $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELUT’s FA Score shows that 0 FA rating(s) are green whileSTRRP’s FA Score has 2 green FA rating(s).

  • ELUT’s FA Score: 0 green, 5 red.
  • STRRP’s FA Score: 2 green, 3 red.
According to our system of comparison, STRRP is a better buy in the long-term than ELUT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELUT’s TA Score shows that 5 TA indicator(s) are bullish.

  • ELUT’s TA Score: 5 bullish, 3 bearish.

Price Growth

ELUT (@Medical Specialties) experienced а +1.16% price change this week, while STRRP (@Medical Specialties) price change was +3.34% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.05%. For the same industry, the average monthly price growth was +6.38%, and the average quarterly price growth was -0.64%.

Reported Earning Dates

ELUT is expected to report earnings on Aug 06, 2025.

STRRP is expected to report earnings on Mar 21, 2025.

Industries' Descriptions

@Medical Specialties (+0.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STRRP YTD gains are higher at: 10.476 vs. ELUT (-53.476). STRRP has higher annual earnings (EBITDA): -1.69M vs. ELUT (-31.68M). STRRP has more cash in the bank: 23.2M vs. ELUT (19.3M). STRRP has less debt than ELUT: STRRP (3.61M) vs ELUT (24M). STRRP has higher revenues than ELUT: STRRP (45.8M) vs ELUT (24.7M).
ELUTSTRRPELUT / STRRP
Capitalization76.5MN/A-
EBITDA-31.68M-1.69M1,878%
Gain YTD-53.47610.476-510%
P/E RatioN/AN/A-
Revenue24.7M45.8M54%
Total Cash19.3M23.2M83%
Total Debt24M3.61M665%
TECHNICAL ANALYSIS
Technical Analysis
ELUT
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 17 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ELUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFIPX25.75N/A
N/A
Franklin Global Equity A
ABYEX9.15N/A
N/A
AB Emerging Markets Multi-Asset Advisor
HFMVX34.96N/A
N/A
Hartford MidCap R6
VWYKX39.29N/A
N/A
Voya Small Cap Growth W
GQSCX12.62-0.37
-2.85%
Glenmede Disciplined US Small Cap Eq Ptf

ELUT and

Correlation & Price change

A.I.dvisor tells us that ELUT and RBOT have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELUT and RBOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELUT
1D Price
Change %
ELUT100%
-4.40%
RBOT - ELUT
31%
Poorly correlated
-3.13%
MHUA - ELUT
29%
Poorly correlated
-3.70%
STRRP - ELUT
23%
Poorly correlated
N/A
TWST - ELUT
23%
Poorly correlated
-7.89%
STRR - ELUT
23%
Poorly correlated
-0.00%
More

STRRP and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRRP has been closely correlated with CVRX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if STRRP jumps, then CVRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRRP
1D Price
Change %
STRRP100%
N/A
CVRX - STRRP
67%
Closely correlated
-10.44%
ACRS - STRRP
52%
Loosely correlated
-4.44%
ANGO - STRRP
48%
Loosely correlated
+0.63%
ELUT - STRRP
46%
Loosely correlated
-4.40%
ZIMV - STRRP
46%
Loosely correlated
-4.05%
More